Gyedu Adam, Gaskill Cameron E, Agbedinu Kwabena, Salazar Daniela Rebollo, Kingham T Peter
Department of Surgery, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, University Hospital, KNUST, Kumasi, Ghana.
Department of Surgery, University of Washington, Seattle, Washington.
J Surg Oncol. 2018 Sep;118(3):581-587. doi: 10.1002/jso.25168. Epub 2018 Aug 10.
Outcome data after surgery for cancer in Sub-Saharan Africa are insufficient. We aimed to describe the presentation and outcomes of patients with solid cancers managed at a tertiary hospital in Ghana.
Records of cancer patients admitted to Komfo Anokye Teaching Hospital general surgery wards from 2013 to 2016 were reviewed for data on presentation, staging, management, and mortality. Patients discharged alive were followed-up by biannual telephone calls to establish their postdischarge status. Survival analysis was performed for patients with pathologic or radiologic confirmation of cancer and adequate staging.
A total of 343 patients were included. Of these, 76% were female. The most common diagnoses were breast 136 (40%), foregut 70 (20%), and colorectal 63 (18%) cancers. Cancer diagnosis was confirmed by pathology or radiology in 281 (82%) patients, but only 112 (40%) had adequate staging. Seventy-four (66%) patients were stage IV. Two-year overall survival for all 343 patients was 22% to 69%, depending on cancer site. Among those with adequate staging who were alive after postoperative 90 days, 3-year survival was similar for curative compared with palliative operations (P = 0.64).
Improved capacity for both therapeutic and palliative cancer care is needed to achieve better outcomes by more appropriate allocation of surgery with respect to the goal of treatment.
撒哈拉以南非洲地区癌症手术后的结局数据不足。我们旨在描述在加纳一家三级医院接受治疗的实体癌患者的临床表现及结局。
回顾2013年至2016年入住科姆福·阿诺克耶教学医院普通外科病房的癌症患者记录,以获取有关临床表现、分期、治疗及死亡率的数据。对存活出院的患者每半年进行一次电话随访,以确定其出院后的状况。对经病理或影像学确诊且分期充分的癌症患者进行生存分析。
共纳入343例患者。其中,76%为女性。最常见的诊断为乳腺癌136例(40%)﹑前肠癌70例(20%)和结直肠癌63例(18%)。281例(82%)患者经病理或影像学确诊为癌症,但只有112例(40%)分期充分。74例(66%)患者为IV期。根据癌症部位不同,343例患者的两年总生存率为22%至69%。在术后90天存活且分期充分的患者中,根治性手术与姑息性手术的3年生存率相似(P = 0.64)。
需要提高癌症治疗及姑息治疗的能力,以便根据治疗目标更合理地分配手术,从而取得更好的治疗效果。